Skip to main content
Log in

Inhibition of proinflammatory pathways by bioactive fraction of Tinospora cordifolia

  • Original Article
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Tinospora cordifolia (Willd.) Miers ex Hook. f. & Thomson, a known immunomodulatory agent extensively used in ayurveda, has not been effectively validated for the mechanisms involved in immunomodulation and the identification of the active principles. The bioactive fraction of T. cordifolia (TBF) in methanol was used for nitric oxide (NO) radical scavenging activity, lipoxygenase (LOX) and cyclooxygenase (COX) dual inhibition and cytotoxicity studies. Production of the proinflammatory cytokines, tumour necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) in dendritic cell (DC) suspensions treated with lipopolysaccharide (LPS) was also studied. The bioactive principles involved were identified with ultra-performance liquid chromatography-quadrupole-time of flight mass spectrometric (UPLC-Q-ToF MS/MS) system. The results indicate significantly higher potency of TBF as compared to positive standards for LOX/COX inhibition with moderate NO radical scavenging activity and the fraction was also found to be non-cytotoxic to monocyte cells. A significant inhibition was also observed in TNF-α and IL-1β production in LPS-treated DC suspensions as compared to standards, rolipram and dexamethasone, respectively. 11 compounds were identified from TBF by MS/MS system. The potent inhibition of LOX and COX enzymes with moderate NO scavenging was indicative of a free radical scavenging-independent mechanism of immunomodulation. Further investigations into the active principles identified would result in the development of lead candidates with potent therapeutic implications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Broderick KE, Feala J, McCulloch A, Paternostro G, Sharma VS, Pilz RB, Boss GR (2006) The nitric oxide scavenger cobinamide profoundly improves survival in a Drosophila melanogaster model of bacterial sepsis. FASEB J 20:1865–1873. doi:10.1096/fj.06-5780com

    Article  CAS  PubMed  Google Scholar 

  • Caminschi I, Lahoud MH, Shortman K (2009) Enhancing immune responses by targeting antigen to DC. Eur J Immunol 39:931–938. doi:10.1002/eji.200839035

    Article  CAS  PubMed  Google Scholar 

  • Chang DM, Baptiste P, Schur PH (1990) The effect of antirheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. J Rheumatol 17(9):1148–1157

    CAS  PubMed  Google Scholar 

  • Choi J-H, Do Y, Cheong C, Koh H, Boscardin SB, Oh Y-S, Bozzacco L, Trumpfheller C, Park CG, Steinman RM (2009) Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J Exp Med 206:497–505. doi:10.1084/jem.20082129

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Copeland RA, Williams JM, Giannaras J, Nurnberg S, Covington M, Pinto D, Pick S, Trzaskos JM (1994) Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. Proc Natl Acad Sci USA 91:11202–11206

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • De Caterina R, Zampolli A (2004) From asthma to atherosclerosis—5-lipoxygenase, leukotrienes, and inflammation. N Engl J Med 350:4–7. doi:10.1056/NEJMp038190

    Article  PubMed  Google Scholar 

  • Dinarello CA (2000) Proinflammatory cytokines. Chest 118:503–508

    Article  CAS  PubMed  Google Scholar 

  • Fiorucci S, Meli R, Bucci M, Cirino G (2001) Dual inhibitors of cyclooxygenase and 5-lipoxygenase. A new avenue in anti-inflammatory therapy? Biochem Pharmacol 62:1433–1438

    Article  CAS  PubMed  Google Scholar 

  • Gheorghe KR, Korotkova M, Catrina AI, Backman L, Af Klint E, Claesson H-E, Rådmark O, Jakobsson P-J (2009) Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids. Arthritis Res Ther 11:R83. doi:10.1186/ar2717

    Article  PubMed  PubMed Central  Google Scholar 

  • Gordaliza M, García PA, del Corral JMM, Castro MA, Gómez-Zurita MA (2004) Podophyllotoxin: distribution, sources, applications and new cytotoxic derivatives. Toxicon 44:441–459. doi:10.1016/j.toxicon.2004.05.008

    Article  CAS  PubMed  Google Scholar 

  • Hsi LC, Wilson LC, Eling TE (2002) Opposing effects of 15-Lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate: alteration in peroxisome proliferator-activated receptor. J Biol Chem 277:40549–40556. doi:10.1074/jbc.M203522200

    Article  CAS  PubMed  Google Scholar 

  • Jacob J, Kumar PB (2013) Ayurvedic herb, Tinospora cordifolia: validation of anti-inflammatory and immunomodulatory activity by effect on inflammatory mediators, TNF-α and lipoxygenase isozymes. JPRBioMedRx Int J 1(9):861–864

    Google Scholar 

  • Jacob J, Prakash KB, Abhimannue AP, Mohan M, Babu BM (2014) Inhibition of lipoxygenase enzymes by extracts of Tinospora cordifolia: a study of enzyme kinetics. J Nat Prod 7:203–209

    Google Scholar 

  • Kern JA, Lamb RJ, Reed JC, Daniele RP, Nowell PC (1988) Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest 81(1):237–244

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Korhonen R, Hömmö T, Keränen T, Laavola M, Hämäläinen M, Vuolteenaho K, Lehtimäki L, Kankaanranta H, Moilanen E (2013) Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1. Br J Pharmacol 169(7):1525–1536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lambrecht BN, Salomon B, Klatzmann D, Pauwels RA (1998) Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice. J Immunol 160:4090–4097

    CAS  PubMed  Google Scholar 

  • Li Z, Geng Y-N, Jiang J-D, Kong W-J (2014) Antioxidant and anti-inflammatory activities of berberine in the treatment of diabetes mellitus. Evid Based Complement Alternat Med 2014:289264. doi:10.1155/2014/289264

    PubMed  PubMed Central  Google Scholar 

  • Marjanović M, Kralj M, Supek F, Frkanec L, Piantanida I, Smuc T, Tusek-Bozić L (2007) Antitumor potential of crown ethers: structure-activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores. J Med Chem 50:1007–1018. doi:10.1021/jm061162u

    Article  PubMed  Google Scholar 

  • Palmer G, Guerne PA, Mezin F, Maret M, Guicheux J, Goldring MB, Gabay C (2002) Production of interleukin-1 receptor antagonist by human articular chondrocytes. Arthritis Res Therapy 4(3):226–231

    Article  CAS  Google Scholar 

  • Parente L (2001) Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? J Rheumatol 28:2375–2382

    CAS  PubMed  Google Scholar 

  • Pereira BJG, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA (1994) Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890–896. doi:10.1038/ki.1994.117

    Article  CAS  PubMed  Google Scholar 

  • Pinto NB, Morais TC, Carvalho KMB, Silva CR, Andrade GM, Brito GAC, Veras ML, Pessoa ODL, Rao VS, Santos FA (2010) Topical anti-inflammatory potential of Physalin E from Physalis angulata on experimental dermatitis in mice. Phytomedicine 17(10):740–743. doi:10.1016/j.phymed.2010.01.006

    Article  CAS  PubMed  Google Scholar 

  • Singh BP, Deepa (2015) Concept of immunomodulation in ayurveda and some immunomodulatory herbs. Int Ayurvedic Med J 3(7):2205–2212

    Google Scholar 

  • Souness JE, Griffin M, Maslen C, Ebsworth K, Scott LC, Pollock K, Palfreyman MN, Karlsson JA (1996) Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a ‘low-affinity’ phosphodiesterase 4 conformer. Br J Pharmacol 118(3):649–658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Steinman RM (1991) The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271–296. doi:10.1146/annurev.iy.09.040191.001415

    Article  CAS  PubMed  Google Scholar 

  • Tsai P-J, Tsai T-H, Yu C-H, Ho S-C (2007) Comparison of NO-scavenging and NO-suppressing activities of different herbal teas with those of green tea. Food Chem 103:181–187. doi:10.1016/j.foodchem.2006.08.013

    Article  CAS  Google Scholar 

  • Verma R, Juvekar AR, Gopalkrishnan R (2006) Bioassay guided purification of an immunomodulatory polysaccharide from roots of Tinospora cordifolia. Planta Medica 72(11):P_002. doi:10.1055/s-2006-949802

  • Wang P, Myers JG, Wu P, Cheewatrakoolpong B, Egan RW, Billah MM (1997) Expression, purification, and characterization of human cAMP-specific phosphodiesterase (PDE4) subtypes A, B, C, and D. Biochem Biophys Res Commun 234:320–324

    Article  CAS  PubMed  Google Scholar 

  • Yang K, Ma W, Liang H, Ouyang Q, Tang C, Lai L (2007) Dynamic simulations on the arachidonic acid metabolic network. PLoS Comput Biol 3:e55. doi:10.1371/journal.pcbi.0030055

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang J-M, An J (2007) Cytokines, inflammation, and pain. Int Anesthesiol Clin 45:27–37. doi:10.1097/AIA.0b013e318034194e

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Dineep Devadasan, Inter University Instrumentation Center, Mahatma Gandhi University, Kottayam, Kerala for MS/MS instrumentation and the Department of Biotechnology BUILDER Programme (Grant Number: BT/PR4800/INF/22/152/2012) for other instrumentation facilities. The study was supported by Grants from the Department of Biotechnology, Ministry of Science and Technology, New Delhi (Grant Number: BT/PR14926/PBD/17/720/2010).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Prakash Kumar.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 765 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jacob, J., Babu, B.M., Mohan, M.C. et al. Inhibition of proinflammatory pathways by bioactive fraction of Tinospora cordifolia . Inflammopharmacol 26, 531–538 (2018). https://doi.org/10.1007/s10787-017-0319-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-017-0319-2

Keywords

Navigation